Revenue: The sum of all revenue fields included for a company's operating activities.
Cyclacel Pharmaceuticals, Inc. (CYCC) had Revenue of $0.04M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$0.04M |
$-11.21M |
|
-- |
|
$0.04M |
|
$12.05M |
|
$-12.00M |
|
$0.01M |
|
$-11.99M |
|
$-11.99M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-12.00M |
|
$-12.00M |
|
0.33M |
|
0.33M |
|
$-33.44 |
|
$-33.44 |
|
| Balance Sheet Financials | |
$3.67M |
|
$0.00M |
|
$0.42M |
|
$4.09M |
|
$6.27M |
|
-- |
|
-- |
|
$6.27M |
|
$-2.17M |
|
$-2.17M |
|
$-2.17M |
|
0.55M |
|
| Cash Flow Statement Financials | |
$-7.99M |
|
-- |
|
$7.82M |
|
$3.38M |
|
$3.14M |
|
$-0.24M |
|
$0.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-27916.28% |
|
-27916.28% |
|
-27902.33% |
|
-27893.02% |
|
-26074.42% |
|
$-7.99M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
515.73% |
|
515.73% |
|
-273.86% |
|
515.73% |
|
$-3.93 |
|
$-23.87 |
|
$-23.87 |
|